OVERVIEW

The Nantz National Alzheimer Center symposium will examine the striking advances made in the identification of plasma biomarkers for Alzheimer’s disease and related disorders. Plasma biomarkers will allow for the identification of people at risk and, likely, for measuring the speed of disease progression. Thus, they will be critical in clinical trials and for the application of new therapies.

TARGET AUDIENCE

Physicians, scientists with an interest in neurobiology, neuropsychologists, speech pathologists, physician assistants, nurse practitioners, nurses, physical therapists, occupational therapists, social workers, residents and fellows

ACCREDITATION

Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Houston Methodist designates this Live activity for a maximum of 5.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For more information please visit the official event page.